Cas no 201996-57-8 (Cytidine-1'-13C)
Cytidine-1'-13C Chemical and Physical Properties
Names and Identifiers
-
- [1'-13C]cytidine
- Cytidine-1'-13C
- 4-Amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)(213C)oxolan-2-yl]pyrimidin-2-one
-
- Inchi: 1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m1/s1/i8+1
- InChI Key: UHDGCWIWMRVCDJ-URLSOCJKSA-N
- SMILES: O1[C@H](CO)[C@H]([C@H]([13C@@H]1N1C(N=C(C=C1)N)=O)O)O
Computed Properties
- Exact Mass: 244.08887536 g/mol
- Monoisotopic Mass: 244.08887536 g/mol
- Isotope Atom Count: 1
- Hydrogen Bond Donor Count: 4
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 17
- Rotatable Bond Count: 2
- Complexity: 383
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 4
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Molecular Weight: 244.21
- XLogP3: -2.1
- Topological Polar Surface Area: 129
Cytidine-1'-13C Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | C998302-2.5mg |
Cytidine-1'-13C |
201996-57-8 | 2.5mg |
$155.00 | 2023-05-18 | ||
| TRC | C998302-25mg |
Cytidine-1'-13C |
201996-57-8 | 25mg |
$1206.00 | 2023-05-18 | ||
| A2B Chem LLC | AF63557-50mg |
Cytidine-1'-13C |
201996-57-8 | 50mg |
$414.00 | 2024-04-20 | ||
| A2B Chem LLC | AF63557-100mg |
Cytidine-1'-13C |
201996-57-8 | 100mg |
$667.00 | 2024-04-20 | ||
| A2B Chem LLC | AF63557-250mg |
Cytidine-1'-13C |
201996-57-8 | 250mg |
$1261.00 | 2024-04-20 | ||
| 1PlusChem | 1P00C3GL-100mg |
Cytidine-1'-13C |
201996-57-8 | 100mg |
$667.00 | 2025-02-25 | ||
| 1PlusChem | 1P00C3GL-50mg |
Cytidine-1'-13C |
201996-57-8 | 50mg |
$417.00 | 2025-02-25 | ||
| 1PlusChem | 1P00C3GL-250mg |
Cytidine-1'-13C |
201996-57-8 | 250mg |
$1255.00 | 2025-02-25 | ||
| SHENG KE LU SI SHENG WU JI SHU | sc-500598-2.5mg |
Cytidine-1'-13C, |
201996-57-8 | 2.5mg |
¥2256.00 | 2023-09-05 | ||
| Biosynth | NC34301-25 mg |
1'-13CCytidine |
201996-57-8 | 25mg |
$224.75 | 2023-01-03 |
Cytidine-1'-13C Related Literature
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
-
Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
-
Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
-
Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
Additional information on Cytidine-1'-13C
In-Depth Analysis of Cytidine-1'-13C (CAS No. 201996-57-8): Applications, Isotopic Labeling, and Research Trends
Cytidine-1'-13C (CAS No. 201996-57-8) is a stable isotope-labeled nucleoside widely used in biomedical research, metabolic studies, and pharmaceutical development. As a carbon-13 labeled derivative of cytidine, this compound plays a pivotal role in NMR spectroscopy, tracer studies, and RNA metabolism research. The growing demand for isotopically labeled compounds in drug discovery and life sciences has positioned Cytidine-1'-13C as a valuable tool for researchers investigating nucleic acid dynamics and cellular processes.
The unique 13C labeling at the 1'-position of the ribose moiety makes this compound particularly useful for metabolic flux analysis and isotopic tracing experiments. Recent studies utilizing Cytidine-1'-13C have provided groundbreaking insights into cancer cell metabolism, viral replication mechanisms, and mitochondrial function—all hot topics in current biomedical research. The compound's stability and specificity have made it indispensable for advanced mass spectrometry-based proteomics and structural biology applications.
From a chemical perspective, Cytidine-1'-13C maintains identical physical and chemical properties to natural cytidine, except for the isotopic enrichment at the 1'-carbon. This characteristic allows researchers to track the compound's incorporation into RNA molecules or metabolic pathways without altering biological behavior. The pharmaceutical industry particularly values this property when studying drug metabolism and nucleoside analog therapeutics, especially for antiviral and anticancer applications.
The synthesis of Cytidine-1'-13C involves sophisticated organic chemistry techniques to ensure high isotopic purity (>99% 13C) and chemical integrity. Current manufacturing processes focus on cost-effective production methods to meet the growing demand from academic institutions and biotech companies. Quality control measures typically include HPLC analysis, mass spectrometry verification, and NMR characterization to guarantee batch-to-batch consistency.
Recent advancements in RNA sequencing technologies and single-cell analysis have created new applications for Cytidine-1'-13C. Researchers are now using this labeled nucleoside to investigate epigenetic modifications, RNA turnover rates, and post-transcriptional regulation—areas receiving significant attention in molecular biology circles. The compound's utility in studying COVID-19 viral RNA synthesis mechanisms has particularly increased its visibility in the past three years.
The market for isotope-labeled nucleosides like Cytidine-1'-13C is projected to grow steadily, driven by expanding research in personalized medicine and RNA-based therapeutics. Pharmaceutical companies are increasingly incorporating these tools into their drug development pipelines, especially for mRNA vaccine research and antisense oligonucleotide therapies. This trend aligns with the broader industry shift toward precision medicine approaches.
Proper storage and handling of Cytidine-1'-13C are crucial for maintaining its stability and performance. The compound should be stored at -20°C in a dry environment, protected from light and moisture. Researchers working with this material should follow standard laboratory safety protocols and consider the compound's relatively higher cost compared to non-labeled cytidine when planning experiments.
Future research directions involving Cytidine-1'-13C may include applications in artificial intelligence-assisted drug discovery and quantum biology studies. The compound's ability to provide precise metabolic information makes it valuable for emerging fields like systems biology and computational biochemistry. As analytical techniques continue to advance, the demand for high-quality 13C-labeled compounds is expected to rise accordingly.
For researchers considering Cytidine-1'-13C for their studies, it's important to consult recent literature on optimal experimental designs for isotope incorporation studies. Many peer-reviewed publications now provide detailed protocols for using this compound in various applications, from cell culture experiments to in vivo metabolic tracing. Proper experimental design can maximize the value obtained from this specialized research reagent.
The scientific community continues to discover new applications for Cytidine-1'-13C as analytical technologies evolve. Its role in advancing our understanding of RNA biology and cellular metabolism ensures its ongoing relevance in cutting-edge research. As the fields of genomics and metabolomics converge, compounds like Cytidine-1'-13C will likely play increasingly important roles in bridging these disciplines.
201996-57-8 (Cytidine-1'-13C) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)